6.89
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LFMD?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$6.83
Offen:
$6.76
24-Stunden-Volumen:
2.00M
Relative Volume:
0.99
Marktkapitalisierung:
$326.71M
Einnahmen:
$193.06M
Nettoeinkommen (Verlust:
$-22.51M
KGV:
-10.77
EPS:
-0.64
Netto-Cashflow:
$10.63M
1W Leistung:
+5.51%
1M Leistung:
-38.81%
6M Leistung:
-5.23%
1J Leistung:
+25.05%
Lifemd Inc Stock (LFMD) Company Profile
Firmenname
Lifemd Inc
Sektor
Branche
Telefon
(866) 351-5907
Adresse
236 FIFTH AVENUE, NEW YORK
Vergleichen Sie LFMD mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
LFMD
Lifemd Inc
|
6.89 | 323.86M | 193.06M | -22.51M | 10.63M | -0.64 |
![]()
VEEV
Veeva Systems Inc
|
279.18 | 45.01B | 2.86B | 780.66M | 1.20B | 4.72 |
![]()
TEM
Tempus Ai Inc
|
69.63 | 11.53B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
64.02 | 11.58B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
HQY
Healthequity Inc
|
89.27 | 8.04B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
35.35 | 6.03B | 906.14M | -52.62M | 89.62M | -0.3621 |
Lifemd Inc Stock (LFMD) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-06-18 | Bestätigt | BTIG Research | Buy |
2024-12-10 | Eingeleitet | Lake Street | Buy |
2024-12-04 | Eingeleitet | Mizuho | Neutral |
2024-08-23 | Fortgesetzt | B. Riley Securities | Buy |
2024-06-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
2023-11-30 | Eingeleitet | Craig Hallum | Buy |
2023-07-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
2023-07-03 | Eingeleitet | H.C. Wainwright | Buy |
2022-03-10 | Eingeleitet | Colliers Securities | Buy |
2021-10-04 | Fortgesetzt | B. Riley Securities | Buy |
Alle ansehen
Lifemd Inc Aktie (LFMD) Neueste Nachrichten
Rosen Law Firm Encourages LifeMD, Inc. Investors to Inquire About Securities Class Action Investigation – LFMD - Business Wire
Digital health Q2 earnings: New guys win, GLP-1 companies lose - Modern Healthcare
Dynex Capital, Inc. Declares Monthly Common Stock Dividend of $0.17 Per Common Share for August 2025 - The Globe and Mail
Is LifeMD Inc. a top pick in the sectorBuyback Announcements Stock Watch - thegnnews.com
HC Wainwright Lowers LifeMD Price Target to $13.00, Maintains "Buy" Rating - AInvest
LifeMD price target lowered to $13 from $14 at H.C. Wainwright - TipRanks
LifeMD, Inc. (NASDAQ:LFMD) Q2 2025 Earnings Call Transcript - Insider Monkey
Positive Sentiment Still Eludes LifeMD, Inc. (NASDAQ:LFMD) Following 46% Share Price Slump - simplywall.st
LifeMD Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
LifeMD (LFMD) Target Price Lowered by HC Wainwright & Co. to $13 - GuruFocus
LifeMD’s Strong Growth Potential and Strategic Diversification Support Buy Rating Despite Revenue Guidance Adjustment - TipRanks
LifeMD: HC Wainwright lowers Buy rating to $13 from $14. - AInvest
Tidewater Inc.’s Financial Stability at Risk: How Debt Covenants Threaten Liquidity and Growth - The Globe and Mail
LifeMD, Inc. (LFMD) Reports Q2 Loss, Lags Revenue Estimates - MSN
LifeMD Earnings Call: Mixed Sentiments and Strategic Moves - TipRanks
LifeMD Expects Q3 Adjusted EBITDA of $6M-$7M, Revenue Growth at 19.5%, and Mixed Financial Health - AInvest
LifeMD Reports Q2 2025 Revenue Growth of 23% to $62.2mln, Adjusted EBITDA Surges 223% to $7.1mln. - AInvest
LifeMD Stock Plummets 40%. Why Weight Loss Isn't Just A Gimme. - Investor's Business Daily
LifeMD shares drop 44.55% intraday despite Q2 revenue growth and debt repayment. - AInvest
LifeMD stock price target lowered to $12 at KeyBanc on elevated costs - Investing.com Nigeria
LifeMD price target lowered to $14 from $18 at Lake Street - TipRanks
LifeMD Misses Estimates, But Keeps Growing And Diversifying - Finimize
LifeMD Down Nearly 46%, on Track for Record Percent Decrease -- Data Talk - 富途牛牛
Lake Street Initiates LifeMD(LFMD.US) With Buy Rating, Announces Target Price $14 - 富途牛牛
LifeMD Plummets 44%: A Telehealth Titan's Turbulent Turnaround? - AInvest
LifeMD (LFMD) Analyst Lowers Price Target but Maintains Overweig - GuruFocus
LifeMD Plummets 40.96%: Earnings Shock and Sector Headwinds Spark Investor Exodus - AInvest
LifeMD slumps after firm cuts 2025 revenue forecast - TradingView
TR | OpenAI4o Maintains LifeMD(LFMD.US) With Hold Rating, Cuts Target Price to $12.5 - 富途牛牛
KeyBanc Adjusts LifeMD (LFMD) Price Target Amid Business Strateg - GuruFocus
LifeMD 2025 Q2 Earnings Significant Loss Reduction - AInvest
LifeMD (LFMD) Q2 Revenue Rises 23% - The Globe and Mail
LifeMD, Inc. Reports Strong Q2 2025 Growth - TipRanks
LifeMD’s CEO Makes a Bold Move with Significant Stock Sale - TipRanks
LifeMD's Q2 2025 Earnings Call: Navigating Contradictions in Insurance Strategy and Customer Acquisition Costs - AInvest
LifeMD (LFMD) Revenues and Earnings Miss Expectations - GuruFocus
LifeMD (LFMD) Updates Financial Guidance Amid Revenue Growth - GuruFocus
Earnings call transcript: LifeMD Q2 2025 misses expectations, stock dips - Investing.com
LifeMD CEO Schreiber sells $249,690 in shares By Investing.com - Investing.com Nigeria
LifeMD CEO Schreiber sells $249,690 in shares - Investing.com
LifeMD August 2025 slides: Virtual healthcare platform targets $255M in 2025 revenue - Investing.com Canada
LifeMD August 2025 slides: Virtual healthcare platform targets $255M in 2025 revenue By Investing.com - Investing.com South Africa
LifeMD reports Q2 EPS (6c) vs. (19c) last year - TipRanks
LifeMD shares plunge as Q2 results miss, guidance cut By Investing.com - Investing.com Canada
LifeMD shares plunge as Q2 results miss, guidance cut - Investing.com
LifeMD cuts FY25 revenue view to $250M-$255M from $268M-$275M - TipRanks
LifeMD Q2 revenue rises but misses expectations - MarketScreener
LifeMD earnings missed by $0.04, revenue fell short of estimates - Investing.com Canada
LifeMD Reports Second Quarter 2025 Results - GlobeNewswire
LifeMD Inc (LFMD) Q2 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
LifeMD to Participate in the Canaccord Genuity 45th Annual Growth Conference - GlobeNewswire
Finanzdaten der Lifemd Inc-Aktie (LFMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):